Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 140 (4) , 439-444
- https://doi.org/10.1067/mpd.2002.121936
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Megestrol Acetate Treatment of Growth Failure in Children Infected With Human Immunodeficiency VirusPediatrics, 1997
- Megestrol acetate therapy for anorexia and weight loss in children with malignant solid tumoursAlimentary Pharmacology & Therapeutics, 1996
- A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosisThe Journal of Pediatrics, 1995
- Megestrol Acetate in Patients with AIDS and CachexiaAnnals of Internal Medicine, 1994
- Usefulness of Megestrol Acetate in Cancer Cachexia and AnorexiaAmerican Journal of Clinical Oncology, 1992
- Nutritional assessment and management in cystic fibrosis: a consensus reportThe American Journal of Clinical Nutrition, 1992
- Relation between Tumor Necrosis Factor-alpha and Granulocyte Elastase-α1-Proteinase Inhibitor Complexes in the Plasma of Patients with Cystic FibrosisAmerican Review of Respiratory Disease, 1989
- A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and TorontoJournal of Clinical Epidemiology, 1988
- Gastroesophageal reflux in patients with cystic fibrosisThe Journal of Pediatrics, 1985
- RELATIVE UNDERWEIGHT IN CYSTIC FIBROSIS AND ITS PROGNOSTIC VALUEActa Paediatrica, 1978